New inhaled nausea drug passes early safety check in healthy volunteers
NCT ID NCT04200092
First seen Apr 25, 2026 · Last updated May 08, 2026 · Updated 1 time
Summary
This early-stage study tested an inhaled form of the anti-nausea drug granisetron (called AZ-010) in 36 healthy adults. The goal was to check its safety and how the body processes it, comparing different doses and also comparing it to the standard IV form. Since it only involved healthy volunteers and measured drug levels and side effects, it was a safety and drug-behavior study, not a treatment trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celerion
Tempe, Arizona, 85283, United States
Conditions
Explore the condition pages connected to this study.